March 5, 2020 / 12:24 PM / a month ago

BRIEF-Matinas Biopharma Announces Initiation Of Enhance-It Study Of Mat9001 Against Vascepa

March 5 (Reuters) - Matinas BioPharma Holdings Inc:

* MATINAS BIOPHARMA ANNOUNCES INITIATION OF ENHANCE-IT STUDY OF MAT9001 AGAINST VASCEPA®

* MATINAS BIOPHARMA HOLDINGS INC - TOPLINE DATA EXPECTED Q4 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below